OncoLize

For clinicians and medical users

Dealing with primary tumors or metastasized tumors posing an immediate threat to vital functions can be a major challenge in managing tumor disease and the well-being of your patients. Our injectable drug depots target the tumor in the most direct manner possible: injecting a drug depot inside the tumor mass.

Investors

This is a magnificent opportunity for reward and for impact in oncology. You have heard it all before, we are sure of that. So, we derisked the ChemoGell™ proposition to a considerable length and kept it attractive to step in early and make your ROI count. Even better, we are goint to prove this to you with our led product ChemGem to deal with one of the most notorious cancers ut there: Pancreatic cancer, more specifically PDAC.

For Pharma, Biotech and strategic Partners

(After having identified and developed a new oncology drug), With your new oncology drug candidate you need to deliver your asset where it makes most sense, and at the most optimal price point… In many cases we see major opportunities for advanced delivery in, or near, the tumor mass that you target.

For patients and public

What if we can turn oncology drug delivery upside down? To deliver oncology drugs locally, inside the targeted tumors, where they should be. And then keep them there, increase efficacy in eradication of tumors, reduce the serious side effects and the total cost of care?

OncoLize develops injectable drug depots to deliver oncology drugs where they matter most: inside tumors.